Developing image analysis algorithms relevant to immune-oncology

Philip Macklin is a clinician and histopathology trainee in the Oxford Deanery, currently taking time out of NHS training to complete a DPhil in Clinical Medicine. He has a medical degree from the University of Edinburgh and has been working in Oxford ever since. He is currently a Clinical Research Fellow in the Ratcliffe/Pugh Hypoxia Biology group based in the Nuffield Department of Medicine.

Philip is investigating how hypoxia within solid tumours affects anti-tumour immune responses. He is looking into whether manipulating levels of tumour hypoxia, or how infiltrating immune cells respond to this hypoxia, can increase the power of these responses to better control the growth and spread of tumours. He is particularly interested in the effects of hypoxia on the spatial distribution of different immune cell subsets within the tumour microenvironment. To do this accurately, he is collaborating with local mathematicians and software engineers to develop computer algorithms to perform robust/reliable image analysis of histology sections. Such approaches generate large datasets and, in parallel, he is developing techniques to curate and visualise the results as well as more sophisticated spatial statistics to describe these distributions.

He hopes to develop these approaches into freely available and easy to use software that will assist other researchers in Oxford to perform accurate image analysis, with particular relevance to immuno-oncology projects. Whilst likely to be used exclusively in the academic setting at first, it is possible that, in the future, these techniques could be applied to patient samples within the diagnostic histopathology laboratory to better quantitate biomarkers/prognostic features in histology images, helping to ensure that each patient receives the most appropriate treatment.

Find out more about our research below

Image from an endoscopy video with the detected artefacts highlighted with coloured boxes.

AI endoscopy enables 3D surface measurements of pre-cancerous conditions in oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team in Oxford has developed an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

New prostate cancer risk tool

A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.
An animation showing a dial with green, amber and red risk levels for myeloma

New clinical prediction tools for myeloma

Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.
Doctor looking at skin

Higher testosterone levels in men linked to greater melanoma risk

New research from Dr Eleanor Watts at the Nuffield Department of Population Health has found this association for the first time

Novel imaging device enters first round of development funding programme

Anna Vella is designing CAPULET: a device to increase the accuracy in delivering particle beam radiotherapy in cancer treatment

Funding to improve childhood, teenage and young adult cancer detection

Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer

New partnership enables access to state-of-the-art radiotherapy machine

University of Oxford, OUH and GenesisCare have partnered to provide access to a new ViewRay MRIdian machine. It is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.

Drinking alcohol regularly increases cancer risk in Chinese populations

New research from the Nuffield Department of Population Health shows that reducing alcohol consumption in China could be an important cancer prevention strategy